Aurora Kinase A and Bcl-xL Inhibition Suppresses Metastasis in Triple-Negative Breast Cancer
Triple-negative breast cancer (TNBC) is a heterogeneous disease that accounts for 10–15% of all breast cancer cases. Within TNBC, the treatment of basal B is the most challenging due to its highly invasive potential, and thus treatments to suppress metastasis formation in this subgroup are urgently...
Main Authors: | Natascha Skov, Carla L. Alves, Sidse Ehmsen, Henrik J. Ditzel |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-09-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/23/17/10053 |
Similar Items
-
Aurora Kinase A-YBX1 Synergy Fuels Aggressive Oncogenic Phenotypes and Chemoresistance in Castration-Resistant Prostate Cancer
by: Kumar Nikhil, et al.
Published: (2020-03-01) -
Bcl-2 Family Members Bcl-xL and Bax Cooperatively Contribute to Bortezomib Resistance in Mantle Cell Lymphoma
by: Sudjit Luanpitpong, et al.
Published: (2022-11-01) -
Combined inhibition of MEK and Aurora A kinase in KRAS/PIK3CA double-mutant colorectal cancer models
by: S. Lindsey eDavis, et al.
Published: (2015-06-01) -
<i>Bcl</i>-<i>xL</i> Promotes the Survival of Motor Neurons Derived from Neural Stem Cells
by: Yunqin Wu, et al.
Published: (2023-01-01) -
Unfolded Protein Response Is Activated by Aurora Kinase A in Esophageal Adenocarcinoma
by: Heng Lu, et al.
Published: (2022-03-01)